• 생약학회지
• /
• 제49권4호
• /
• pp.362-371
• /
• 2018

Hwanggeumjackyak-tang (HJT) composed of Scatellaria baicalensis Georgi, Paeonia Lactiflora and Glycyrrhizae uralensis Fischer is a traditional Korean herbal medicine widely used for acute enteritis. In order to develop the tablet formulation of HJT, evaluation of the flow properties, thickness, diameter, hardness, friability and disintegration was carried out on four HJT granules according to mixed content of seven additives. Simultaneous analysis used HPLC method was performed of HJT tablet and was determined of the seven marker components; Albiflorin, Paeoniflorin, Liquiritin, Baicalin, Baicalein, Glycyrrhizic acid and Wogonin. The biological activities were examined the effect of HJT on anti-oxidation and pro-inflammation mediated by LPS-stimulation. We confirmed that both of HJT-Decoction (HJT-D) and HJT-Formulation (HJT-F) have the similar contents on total polyphenol and flavonoid and inhibited the secretion of nitro oxide (NO), interleukin $(IL)-1{\beta}$,interleukin (IL)-6, tumor necrosis factor $(TNF)-{\alpha}$ and the expression of nitric oxide synthase (iNOS), $IL-1{\beta}$, IL-6, $TNF-{\alpha}$. Therefore, the developed formulation for tablet of HJT would provide chemically and biologically the same effect compared with decoction of HJT.

• 한국식품영양과학회지
• /
• 제42권7호
• /
• pp.1015-1021
• /
• 2013

창과감초(Glycyrrhiza inflata Batal)는 한약재의 조화를 돕고 해독, 항염증, 항궤양 등의 약리작용으로 한방에서 널리 이용되는 약용식물이다. 본 연구에서는 지방세포와 조골세포에서 감초의 생리활성을 확인하고자 감초에탄올추출물(GBE)을 이용하여 세포분화 촉진여부를 조사하였다. GBE의 세포독성여부를 통해 안전하다고 확인된 $1{\sim}30{\mu}g/mL$의 농도 내에서 실험이 진행되었고 지방세포 분화조건에서 다분화능 세포 C3H10T1/2과 지방전구세포 3T3-L1의 Oil Red O 염색을 통해 GBE의 지방세포분화 촉진효과를 확인할 수 있었다. 또한 지방세포의 핵심전사조절인자인 $PPAR{\gamma}$와 그의 표지유전자 aP2, AdipoQ, $C/EBP{\alpha}$의 발현량 증가를 통해 GBE의 지방세포분화 촉진효과를 재확인하였다. 이와 일관된 결과로서 조골세포 분화조건에서 다분화능 세포 C3H10T1/2과 조골전구세포 MC3T3-E1의 ALP 염색을 통해 GBE의 조골세포분화 촉진효과를 확인하였고 조골세포 표지유전자인 ALP, RUNX2, osterix, collagen의 발현량 증가를 통해 GBE의 조골세포분화 촉진효과를 재확인하였다. 이에 따라 본 연구에서는 GBE의 지방세포와 조골세포 분화효과를 매개하는 감초의 구성성분을 조사하기 위해 GA(glycyrrhizic acid)와 LA(licochalcone A)의 분화촉진 여부를 확인한 결과, GA는 영향을 주지 않으나 LA가 GBE의 세포분화효과를 매개한다고 사료된다. 따라서 본 연구에서는 제2형 당뇨와 그에 수반되는 골질환과 골다공증에 대한 치료 소재로서 GBE와 그의 생리활성을 매개할 수 있는 LA의 가능성을 보았으며 GBE에서 분리되는 다양한 화합물의 동정 및 생리활성 효과, LA와의 상승효과 등의 추후 연구가 기대된다.

• Biomolecules & Therapeutics
• /
• 제10권2호
• /
• pp.104-113
• /
• 2002

The effects of enzyme inhibitors and penetration enhancers on the permeation of leucine enkephalin (Leu-Enk) and its synthetic analog, [${D-ala}^2$]-leucine enkephalinamide (YAGFL) across the nasal, rectal and vaginal mucosae were evaluated. Enzyme inhibitors and penetration enhancers employed for Leu-Enk permeation study were amastatin(AM), thimerosal(TM) and ethylenediaminetetraacetic acid disodium salt(EDTA), and sodium taurodihydrofusidate (STDHF). Those for YAGFL permeation study were TM, benzalkonium chloride(BC) and EDTA, and STDHF, sodium deoxycholate(SDC), sodium glycholate(SGC), glycyrrhizic acid ammonium salt (GAA), L-$\alpha$-Iysophosphatidylcholine(LPC) and mixed micelle (MM, STDHF: linoleic acid = 15 mM : 5 mM). The addition of TM alone on the donor and receptor solutions for Leu-Enk permeation study across all the three kinds of mucosae failed to inhibit the degradation; it completely degraded in 6 hrs, and no permeation occurred. However, with addition of three kinds of inhibitors together, the fluxes across nasal, rectal and vaginal mucosae were $\20.7{pm}2.5$>/TEX>,$\0.3{pm}0.05$>/TEX> and $\1.4{pm}0.5$ $\mu$\mid$textrm{m}$/$\textrm{cm}^2$/hr, respectively. Moreover, the addition of STDHF in the presence of the above three inhibitors enhanced permeation across nasal, rectal and vaginal mucosae 1.3, 15 and 1.3 times, respectively. YhGFL also degraded in the donor and receptor solutions rapidly as time went. With mixed inhibitors of TM and EDTA, the percents of YAGFL remaining in the donor solutions facing nasal, rectal and vaginal mucosae were 69.7, 69.8 and 79.8%, respectively; the percent permeated increased to 10, 2.1 and 5.7%, respectively. The addition of STDHF in the presence of either BC/EDTA or TW/EDTA increased the permeation 2.2, 11.0 and 2.9 times, and 2.21, 14.0 and 2.7 times for nasal, rectal and vaginal mucosae, respectively. With SDC, SGC, GAA, LPC ud MM in the presence of TM/EDTA increased permeation; especially, they increased permeation across vaginal mucosae effectively, and the enhancement factors were 12.5, 7.6, 8.7, 5.7 and 5.5, respectively. The degradation extent of YAGFL was correlated with protein concentrations in the epidermal and serosal extracts. The flux of YAGFL across nasal mucosa increased dose-dependently.

• 대한한의학회지
• /
• 제36권4호
• /
• pp.56-68
• /
• 2015

Objectives: This study investigated quality among three herb medicine extract granules(DSGOST) which were made from different companies to check quality control of herb medicine extract granules. Methods: we selected three DSGOST extract granules which were made from different companies. And we experimented extract granules by method from K.P(Korean Pharmacopoeia), K.H.P(Korean Herbal Pharmacopoeia) of KFDA. Results: In qualitative analysis of DSGOST, we indentified Akebiae Caulis (木通), Asari Herba Cum Radix (細辛), Evodiae Fructus (吳茱萸) in three different DSGOST extract granules. In quantitative analysis of DSGOST, Medication A,B,C contained similar content of Paeoniflorin & Glycyrrhizic acid. However Medication B contains especially lowest value of Cinnamic acid & total Decursin. Conclusions: Herb medicine extract granules have different contents of ingredients although those were made by same prescription. And these differences may influence medicinal effect to patients. So we need to make system of quality control with various research of quantitative & qualitative analysis about herb medicine extract granules.

• Toxicological Research
• /
• 제21권4호
• /
• pp.325-332
• /
• 2005

The developmental toxicity of water extract of licorice (Glycyrrhiza glabra) was evaluated in rats. Licorice extract (500, 1,000 or 2,000 mg/kg) was dissolved in drinking water and orally administered to male rats from 9 weeks before mating to the day of copulation, and to females from 2 weeks before mating to gestational day 19. On gestational day 20, the animals were sacrificed for Cesarian section, and maternal and fetal abnormalities were examined. Licorice extract neither induce clinical signs, nor affect the body weight gain, feed and water intake, estrous cycle, copulation and fertility rates, blood $17\beta-estradiol$ level and organ weights of dams. Also, the implantation and development including body weights, absorption and death of embryos and fetuses were not influenced by in utero exposure to licorice. In addition, there were no increases in external, visceral and skeletal abnormalities of fetuses. Taken together, it is suggested that no observed adverse effect level of licorice extract is higher than 2,000 mg/kg, and that long-term in utero exposure to licorice might not cause developmental toxicities of embryos and fetuses.